GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genix Pharmaceuticals Corp (TSXV:GENX) » Definitions » 3-Year Dividend Growth Rate

Genix Pharmaceuticals (TSXV:GENX) 3-Year Dividend Growth Rate : 0.00% (As of Jan. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Genix Pharmaceuticals 3-Year Dividend Growth Rate?

Genix Pharmaceuticals's Dividends per Share for the three months ended in Jan. 2025 was C$0.00.

The historical rank and industry rank for Genix Pharmaceuticals's 3-Year Dividend Growth Rate or its related term are showing as below:

TSXV:GENX's 3-Year Dividend Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 11.45
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Genix Pharmaceuticals's Dividend Payout Ratio for the three months ended in Jan. 2025 was 0.00. As of today, Genix Pharmaceuticals's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Genix Pharmaceuticals's 3-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Genix Pharmaceuticals's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genix Pharmaceuticals's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genix Pharmaceuticals's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Genix Pharmaceuticals's 3-Year Dividend Growth Rate falls into.


;
;

Genix Pharmaceuticals 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Genix Pharmaceuticals  (TSXV:GENX) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Genix Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Jan. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jan. 2025 )/ EPS without NRI (Q: Jan. 2025 )
=0/ 0
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genix Pharmaceuticals 3-Year Dividend Growth Rate Related Terms>


Genix Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically, the company operates only in Canada.
Executives
Sina Pirooz Director
Paul Chow 10% Security Holder, Director
Jamie A. Lewin Director

Genix Pharmaceuticals Headlines

No Headlines